ArticleInternational journal of women's health2026
Global, Regional, and Future Predictions of Cardiovascular Disease Burden Among Women of Childbearing Age: A Systematic Analysis of the Global Burden of Disease Study 1990-2021.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiovascular disease (CVD) continues to be the leading cause of death among women of childbearing age (WCBA) worldwide. An updated, geographically detailed assessment of CVD and its subtype burdens in this population is warranted. Material and Methods: This study utilized the data from GBD 2021 to assess the incidence and mortality of CVD among WCBA across 231 countries and regions from 1990 to 2021. Age-standardised rates (ASRs) and estimated annual percentage changes (EAPCs) were used to assess trends in disease burden from 1990 to 2021. Sociodemographic-index (SDI)-associated disparities were explored using smoothed regression and correlation analysis. Predictions to 2050 were performed using Bayesian age-period-cohort (BAPC) modeling to support forward-looking public health planning. Results: From 1990 to 2021, incident cases and deaths of CVD among WCBA increased from 2.77 million and 0.38 million to 4.49 million and 0.42 million, respectively, despite modest declines in ASR of incidence (ASIR, EAPC: -0.08%) and mortality (ASMR, EAPC: -1.59%). In 2021, ischemic heart disease (IHD) has the highest ASIR (67.53 per 100,000) and ASMR (8.64 per 100,000), and showed the fastest increase in ASIR over time. Marked sociodemographic disparities were observed, with low-SDI regions consistently experiencing higher ASIR (276.61 per 100,000) and ASMR (28.59 per 100,000) of CVD in 2021. Decomposition analysis indicated that population growth was the primary driver of the global increase in both CVD cases and mortality, while population ageing played a greater role in higher-SDI regions, with epidemiological changes partially offsetting mortality increases. Predictions suggest that while ASIR will continue to rise, ASMR is expected to further decline. Conclusion: The global burden of CVD among WCBA remains substantial, with rising incidence in key subtypes such as IHD and persistent disparities across SDI regions, underscoring the need for targeted, subtype-specific prevention strategies and strengthened healthcare systems in high-burden settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.